Targeting P21 positive senescent cells for alleviating TMJ degeneration
Project Number1R01DE033004-01A1
Former Number1R01DE033004-01
Contact PI/Project LeaderYADAV, SUMIT
Awardee OrganizationUNIVERSITY OF NEBRASKA MEDICAL CENTER
Description
Abstract Text
Abstract
Temporomandibular Joint (TMJ) degeneration is a painful and debilitating disease of the synovial joint,
affecting over 20 million people in the United States. Obesity, advancing age and mechanical loading are
greatest risk factor for many diseases including TMJ degeneration. TMJ degeneration significantly impair the
quality of life by causing acute and chronic pain, thus making this disease a global health issue and a financial
burden of epidemic proportion. The incidence of the TMJ degeneration is expected to rise substantially as the
prevalence of obesity has risen dramatically over the last two-decades. As there is no effective treatment for
the TMJ degeneration in an obese and aged individual, there is an unmet clinical need for an effective
approach to treat TMJ degeneration.
The current proposal seeks to address this unmet clinical challenge using a highly innovative approach of
targeting p21 high cells both genetically and therapeutically for the treatment of TMJ degeneration. Our
overarching hypothesis is that p21 high cells plays a central role in obesity, age-related and mechanical loading
induced TMJ degeneration and targeted elimination of the p21 high cells may alleviate TMJ degeneration. To
test this hypothesis, we will define: (1) the role of p21 high cells in osteochondral tissue in obesity and aging
induced TMJ degeneration. Using a novel inducible p21-cre ERT2 X td-Tomato mice we will examine the
effects of p21 high cells on the homeostasis of the osteochondral tissues of the TMJ in obesity and aging. (2)
the pathophysiological mechanism by which p21high cells causes TMJ degeneration. Using the novel mice
model (p21-cre ERT2 X td-Tomato X Rela flox/flox), we will examine the effect NF-κB pathway on the senescent
cells in TMJ degeneration. 3) To define the role of p21high cells in traumatic TMJ injury and repair. p21-cre
ERT2 X td-Tomato mice will be subjected to traumatic injury to TMJ and we will genetically clear the p21 high
cells after traumatic injury to see whether we can alleviate TMJ-OA or repair the damaged cartilage. A
combination of mechanical, immunohistochemical, molecular biology and histomorphometric techniques
coupled with novel genetic mice models will be used to study the proposed specific aims.
The proposed project has the immense potential to reveal new regulatory pathways that controls homeostasis
of the osteochondral tissues of the TMJ in an obese and aged individual and to open new insight on
understanding the disease mechanism and developing therapeutic interventions.
Public Health Relevance Statement
Narrative
Degenerative disorders of Temporomandibular Joint (TMJ) are painful and debilitating diseases, affecting over
20 million people in United States. The prevalence of obesity and growth of older population has risen
dramatically over the past two decades and it has been observed that obesity accelerates aging. Our
application proposes to understand the role of p21–highly-expressed (p21high) cells in TMJ degeneration and
underlying mechanism by which p21high cells modulate TMJ degeneration.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
168559177
UEI
G15AG3BLLMH4
Project Start Date
05-September-2024
Project End Date
30-June-2029
Budget Start Date
05-September-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$399,198
Direct Costs
$260,751
Indirect Costs
$138,447
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$49,198
2024
National Institute of General Medical Sciences
$350,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DE033004-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DE033004-01A1
Patents
No Patents information available for 1R01DE033004-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DE033004-01A1
Clinical Studies
No Clinical Studies information available for 1R01DE033004-01A1
News and More
Related News Releases
No news release information available for 1R01DE033004-01A1
History
No Historical information available for 1R01DE033004-01A1
Similar Projects
No Similar Projects information available for 1R01DE033004-01A1